2015 Investor and Analyst Day

139 Pages·2015·6.55 MB·English

by  Hofmann, Corinne

Investor & Analyst Day 2015
Stäfa | 13 October 2015
Investor & Analyst Day 2015
Program
08.30 Reception, Coffee and Croissants
09.00 Driving innovation in hearing care
Lukas Braunschweiler, CEO
09.45 e-Solutions – The e-Hearingcare opportunity
Martin Grieder, GVP Phonak
Jonathan Gardner, Managing Director Boots Hearingcare
10.30 Coffee break
10.45 Go-to-market – China, exploiting a fast growing market
Albert Chin-Hwee Lim, VP Wholesale Asia/Pacific
11.30 New products – Hearing instruments
Martin Grieder, GVP Phonak
Jan Metzdorff, VP Unitron
12.15 Lunch break
13.30 New products – Cochlear implants
Hansjürg Emch, GVP Medical
14.30 Summary and Q&A
Lukas Braunschweiler, CEO
15.00 Factory tour
2
Disclaimer
This presentation contains forward-looking statements, which offer no guarantee with
regard to future performance. These statements are made on the basis of management’s
views and assumptions regarding future events and business performance at the time the
statements are made. They are subject to risks and uncertainties including, but not
confined to, future global economic conditions, exchange rates, legal provisions, market
conditions, activities by competitors and other factors outside Sonova’s control. Should one
or more of these risks or uncertainties materialize or should underlying assumptions prove
incorrect, actual outcomes may vary materially from those forecasted or expected. Each
forward-looking statement speaks only as of the date of the particular statement, and
Sonova undertakes no obligation to publicly update or revise any forward-looking
statements, except as required by law.
This presentation constitutes neither an offer to sell nor a solicitation to buy any securities.
This presentation does not constitute an offering prospectus within the meaning of Article
652a of the Swiss Code of Obligations nor a listing prospectus within the meaning of the
listing rules of SIX Swiss Exchange.
3
Investor & Analyst Day 2015
Sonova Management Board (MB)
CORP HRM F&A
S&T
MARKETING COM CFO
HI HI HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
CHG RET AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAABBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB R&D OPS
WHS NA WHS EU WWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWWHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSS AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
Albert Lim Martin Grieder Jan Metzdorff Hansjürg Emch
MB team members presenting today
4
Driving innovation in hearing care
Stäfa, Switzerland | 13 October 2015 | Lukas Braunschweiler, CEO
5
1. Sonova Group
6
Summary
Clear and focused strategy – Customer driven innovation – Strong cash conversion
Broadest product and service offering - Phonak, Unitron, Hansaton: Leading position in hearing instruments
- Advanced Bionics: Strong contender on cochlear implants
Significant market share gain potential - High R&D spend – fast product introduction
- Differentiated multi-brand strategy
- Optimized multi-channel approach
Strong and expanding global sales & - Phonak, Unitron, Hansaton, Advanced Bionics: over 50 wholesale group
distribution network companies and more than 100 independent distributors
- Connect Hearing: over 2’000 POS retail clinics in 10 key markets
Strong new product pipelines - High innovation rate and rapid new product introduction
Productivity / efficiency gains - Leverage existing global infrastructure to expand margins
Mid-term financial targets - EBITA margin: expand to mid-twenties at constant FX
(excluding FX impact)
- ROCE: expand to low-thirties
7
Products & services
Broadest and most advanced offering – Hearing instruments, cochlear implants …
HI Hearing Instruments CI Cochlear Implants
(cid:2) Behind-The-Ear hearing instruments (BTE)
(cid:2) Wireless systems
(cid:2) Cochlear implants
(cid:2) Custom In-The-Ear hearing instruments (ITE)
(cid:2) Hearing protection
(cid:2) Wireless communication systems
(cid:2) Invisible extended-wear hearing instruments
… and professional audiological services
8
Sales & distribution
Retail – Strong expansion – Secure access to distribution and consumer
2000 2005 2010 2015
INDEPENDENTS & CHG STORES 2 chains /Branding TBD DE: 100
FR: 200
US: 300
UK: 480
BR: 160
AU/NZ: 170
CA: 110
AT: 80
BE: 250
LARGE RETAIL ACCOUNTS US
UK
VA
AU
AT/CH/DE
US/EU
EU
US/CA/AU
SOON WHOLESALE
GCs in 20 countries
GCs in 20 countries
GCs in 30 countries
Wholesale – Largest global coverage – Support and service HCP partners worldwide

9
Global position & network
Strong global presence – Well established network and infrastructure
AMERICAS EUROPE APAC
10%
46%
44%
Sales CAGR 2010-15 Sales CAGR 2010-15 Sales CAGR 2010-15
+11.0% in LC +13.4% in LC +12.9% in LC
- PH, UT, HA, AB: over 50 wholesale group companies – more than 100 independent distributors
- CHG: over 2’000 POS retail clinics in 10 key markets
- R&D: 6 product and development competence centers (2 CH, 2 US, 1 CA, 1 CN)
- Operations: 4 production centers (1 CH, 1CN, 1 VI, 1 US)
Largest global sales and distribution network in the industry – Wholesale and retail
10